View in EDS HTML Full Text PDF Full Text

Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
Authors: Ji, Tongting1 (AUTHOR), Yang, Yang2 (AUTHOR), Yu, Juanjuan1 (AUTHOR), Yin, Hongli2 (AUTHOR), Chu, Xinran3 (AUTHOR), Yang, Pengju1 (AUTHOR), Xu, Ling1,4 (AUTHOR), Wang, Xiaodong5 (AUTHOR), Hu, Shaoyan3 (AUTHOR), Li, Yizhen2 (AUTHOR), Wu, Xiaochen1 (AUTHOR), Liu, Wengyuan6 (AUTHOR), Zhou, Bi1,7 (AUTHOR), Wang, Wenjuan8 (AUTHOR), Zhang, Shuqi1,9 (AUTHOR), Cheng, Wei1,9 (AUTHOR), Chen, Yanling1 (AUTHOR), Shi, Lei10 (AUTHOR), Li, Zhiheng2 (AUTHOR), Zhuo, Ran1 (AUTHOR)
Source: Journal of Experimental & Clinical Cancer Research (17569966). 7/24/2024, Vol. 43 Issue 1, p1-22. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-024-03130-8